CytoMed TherapeuticsGDTC

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$23.8M

Market Cap • 13/06/2024

2018

(há 6 anos)
Fundação

2023

(1 year ago)
IPO

NASDAQ

Listagem
Flag of SG

Singapore

27

N° de Empregados • 2023

Valuation

Valuation Indicators

Retorno Histórico

GDTCSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-8%

1 dia

11/06/2024

-3%

1 semana

07/06/2024

-8%

1 mês

14/05/2024

-32%

1 ano

14/06/2023

10 anos

Histórico